Literature DB >> 24588674

Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.

Limei Liu1, Jian Liu, Yuansheng Gao, Xiaoxing Yu, Gang Xu, Yu Huang.   

Abstract

BACKGROUND AND
PURPOSE: Uncoupling protein-2 (UCP2) may regulate glucose-stimulated insulin secretion. The current study investigated the effects of berberine, an alkaloid found in many medicinal plants, on oxidative stress and insulin secretion through restoration of UCP2 expression in high glucose (HG)-treated INS-1E cells and rat islets or in db/db mouse islets. EXPERIMENTAL APPROACH: Mouse and rat pancreatic islets were isolated. Nitrotyrosine, superoxide dismutase (SOD)-1 and UCP2 expression and AMPK phosphorylation were examined by Western blotting. Insulin secretion was measured by ELISA. Mitochondrial reactive oxygen species (ROS) production was detected by confocal microscopy. KEY
RESULTS: Incubation of INS-1E cells and rat islets with HG (30 mmol·L(-1); 8 h) elevated nitrotyrosine level, reduced SOD-1 and UCP2 expression and AMPK phosphorylation, and inhibited glucose-stimulated insulin secretion. HG also increased mitochondrial ROS in INS-1E cells. Co-treatment with berberine inhibited such effects. The AMPK inhibitor compound C, the UCP2 inhibitor genipin and adenovirus ucp2 shRNA inhibited these protective effects of berberine. Furthermore, compound C normalized berberine-stimulated UCP2 expression but genipin did not affect AMPK phosphorylation. Islets from db/db mice exhibited elevated nitrotyrosine levels, reduced expression of SOD-1 and UCP2 and AMPK phosphorylation, and decreased insulin secretion compared with those from db/m(+) mice. Berberine also improved these defects in diabetic islets and genipin blocked the effects of berberine. CONCLUSIONS AND IMPLICATIONS: Berberine inhibited oxidative stress and restored insulin secretion in HG-treated INS-IE cells and diabetic mouse islets by activating AMPK and UCP2. UCP2 is an important signalling molecule in mediating anti-diabetic effects of berberine.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  INS-1E cells; berberine; insulin secretion; islets; oxidative stress; uncoupling protein-2

Mesh:

Substances:

Year:  2014        PMID: 24588674      PMCID: PMC4080978          DOI: 10.1111/bph.12666

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.

Authors:  Samuel H H Chan; Kay L H Wu; Peter S S Kung; Julie Y H Chan
Journal:  Hypertension       Date:  2010-04-19       Impact factor: 10.190

4.  8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.

Authors:  Zhe Cheng; An-Feng Chen; Fang Wu; Li Sheng; Han-Kun Zhang; Min Gu; Yuan-Yuan Li; Li-Na Zhang; Li-Hong Hu; Jing-Ya Li; Jia Li
Journal:  Bioorg Med Chem       Date:  2010-07-01       Impact factor: 3.641

5.  Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies.

Authors:  Yunli Yu; Li Liu; Xinting Wang; Xiang Liu; Xiaodong Liu; Lin Xie; Guangji Wang
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

6.  Uncoupling protein 2 regulates reactive oxygen species formation in islets and influences susceptibility to diabetogenic action of streptozotocin.

Authors:  Simon C Lee; Christine A Robson-Doucette; Michael B Wheeler
Journal:  J Endocrinol       Date:  2009-07-27       Impact factor: 4.286

7.  Berberine suppresses proinflammatory responses through AMPK activation in macrophages.

Authors:  Hyun Woo Jeong; Kuan Chi Hsu; Joo-Won Lee; Mira Ham; Jin Young Huh; Hyun Jung Shin; Woo Sik Kim; Jae Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-10       Impact factor: 4.310

Review 8.  On the role of uncoupling protein-2 in pancreatic beta cells.

Authors:  Charles Affourtit; Martin D Brand
Journal:  Biochim Biophys Acta       Date:  2008-04-03

9.  Berberine acutely inhibits insulin secretion from beta-cells through 3',5'-cyclic adenosine 5'-monophosphate signaling pathway.

Authors:  Libin Zhou; Xiao Wang; Li Shao; Ying Yang; Wenbin Shang; Guoyue Yuan; Boren Jiang; Fengying Li; Jingfeng Tang; Hua Jing; Mingdao Chen
Journal:  Endocrinology       Date:  2008-05-29       Impact factor: 4.736

10.  Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function.

Authors:  Jingbo Pi; Yushi Bai; Kiefer W Daniel; Dianxin Liu; Otis Lyght; Diane Edelstein; Michael Brownlee; Barbara E Corkey; Sheila Collins
Journal:  Endocrinology       Date:  2009-02-26       Impact factor: 4.736

View more
  7 in total

1.  Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats.

Authors:  Feng-Hao Geng; Guo-Hua Li; Xing Zhang; Peng Zhang; Ming-Qing Dong; Zhi-Jing Zhao; Yuan Zhang; Ling Dong; Feng Gao
Journal:  Br J Pharmacol       Date:  2016-04-05       Impact factor: 8.739

Review 2.  Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases.

Authors:  Giorgia Pierelli; Rosita Stanzione; Maurizio Forte; Serena Migliarino; Marika Perelli; Massimo Volpe; Speranza Rubattu
Journal:  Oxid Med Cell Longev       Date:  2017-10-15       Impact factor: 6.543

3.  Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats.

Authors:  Yuzhen Jia; Binger Xu; Jisen Xu
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review.

Authors:  Qian Ran; Jin Wang; Lin Wang; Hai-Rong Zeng; Xiang-Bo Yang; Qin-Wan Huang
Journal:  Front Pharmacol       Date:  2019-07-22       Impact factor: 5.810

5.  Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.

Authors:  Wei-Jian Ni; Li-Qin Tang; Hong Zhou; Hai-Hua Ding; Yuan-Ye Qiu
Journal:  J Cell Mol Med       Date:  2016-04-21       Impact factor: 5.310

Review 6.  Role of berberine in Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenming Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-03       Impact factor: 2.570

Review 7.  The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine.

Authors:  Xueling Ma; Zhongjun Chen; Le Wang; Gesheng Wang; Zihui Wang; XiaoBo Dong; Binyu Wen; Zhichen Zhang
Journal:  Front Pharmacol       Date:  2018-07-27       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.